CD133 inhibition via autophagic degradation in pemetrexed-resistant lung cancer cells by GMI, a fungal immunomodulatory protein from Ganoderma microsporum

BACKGROUND: Adaptive drug resistance is an unfavourable prognostic factor in cancer therapy. Pemetrexed-resistant lung cancer cells possess high-metastatic ability via ERK–ZEB1 pathway-activated epithelial–mesenchymal transition. GMI is a fungal immunomodulatory protein that suppresses the survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsin, I-Lun, Chiu, Ling-Yen, Ou, Chu-Chyn, Wu, Wen-Jun, Sheu, Gwo-Tarng, Ko, Jiunn-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403151/
https://www.ncbi.nlm.nih.gov/pubmed/32448867
http://dx.doi.org/10.1038/s41416-020-0885-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403151/
https://www.ncbi.nlm.nih.gov/pubmed/32448867
http://dx.doi.org/10.1038/s41416-020-0885-8

Ejemplares similares